Transgender Care

[1]  S. Reisner,et al.  Transgender Adolescents' Experiences in Primary Care: A Qualitative Study. , 2019, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[2]  Y. Chan,et al.  The Utility of Potassium Monitoring in Gender-Diverse Adolescents Taking Spironolactone , 2019, Journal of the Endocrine Society.

[3]  M. Heijer,et al.  No correlation between serum testosterone levels and state-level anger intensity in transgender people: Results from the European Network for the Investigation of Gender Incongruence , 2019, Hormones and Behavior.

[4]  M. Moravek,et al.  Understudied and Under‐Reported: Fertility Issues in Transgender Youth—A Narrative Review , 2019, The Journal of pediatrics.

[5]  Amy K. Syvertsen,et al.  Transgender Adolescent Suicide Behavior , 2018, Pediatrics.

[6]  Julia M. Przedworski,et al.  Health of Transgender Adults in the U.S., 2014-2016. , 2018, American journal of preventive medicine.

[7]  M. Meriggiola,et al.  Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration , 2018, Clinical endocrinology.

[8]  T. Lash,et al.  Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons , 2018, Annals of Internal Medicine.

[9]  J. Arcelus,et al.  Prospective Evaluation of Self-Reported Aggression in Transgender Persons. , 2018, The journal of sexual medicine.

[10]  Katrina Jane Williams,et al.  Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review , 2018, Pediatrics.

[11]  E. Saewyc,et al.  Non-binary youth: Access to gender-affirming primary health care , 2018 .

[12]  L. Clark,et al.  Physiologic Response to Gender-Affirming Hormones Among Transgender Youth. , 2017, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[13]  G. Quinn,et al.  Fertility Counseling for Transgender AYAs , 2018, Clinical practice in pediatric psychology.

[14]  P. Cohen-Kettenis,et al.  Endocrine Treatment of Gender‐Dysphoric/Gender‐Incongruent Persons: An Endocrine Society* Clinical Practice Guideline , 2017, The Journal of clinical endocrinology and metabolism.

[15]  S. Roberts,et al.  Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents , 2017, Transgender health.

[16]  A. Siafarikas,et al.  Puberty suppression in transgender children and adolescents. , 2017, The lancet. Diabetes & endocrinology.

[17]  Clara P. Savage,et al.  Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients , 2017, The Journal of clinical endocrinology and metabolism.

[18]  D. Keefe,et al.  Pregnancy Outcomes After Fertility Preservation in Transgender Men. , 2017, Obstetrics and gynecology.

[19]  Gylynthia E. Trotman,et al.  Cross-Sex Hormones and Metabolic Parameters in Adolescents With Gender Dysphoria , 2017, Pediatrics.

[20]  G. Castellini,et al.  Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data. , 2016, The Journal of clinical endocrinology and metabolism.

[21]  Cathleen E. Willging,et al.  Stakeholders' Recommendations to Improve Patient-centered “LGBTQ” Primary Care in Rural and Multicultural Practices , 2016, The Journal of the American Board of Family Medicine.

[22]  M. C. Smith Guidelines for psychological practice with transgender and gender nonconforming people. , 2015, The American psychologist.

[23]  David E. Buchholz,et al.  Electronic Health Records and Transgender Patients—Practical Recommendations for the Collection of Gender Identity Data , 2015, Journal of General Internal Medicine.

[24]  Juno Obedin-Maliver,et al.  Transgender Men Who Experienced Pregnancy After Female-to-Male Gender Transitioning , 2014, Obstetrics and gynecology.

[25]  S. Rosenthal,et al.  Psychological and Medical Care of Gender Nonconforming Youth , 2014, Pediatrics.

[26]  A. D. de Vries,et al.  Young Adult Psychological Outcome After Puberty Suppression and Gender Reassignment , 2014, Pediatrics.

[27]  H. Makadon,et al.  Sexual Orientation and Gender Identity Data Collection in Clinical Settings and in Electronic Health Records: A Key to Ending LGBT Health Disparities. , 2014, LGBT health.

[28]  C. Tate,et al.  A Two-Question Method for Assessing Gender Categories in the Social and Medical Sciences , 2013, Journal of sex research.

[29]  L. Clark,et al.  The Gender Affirmative Model: What We Know and What We Aim to Learn , 2013, Human Development.

[30]  Masami Watanabe,et al.  Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder. , 2013, Endocrine journal.

[31]  Alicia L Fedewa,et al.  Effects of “Safe School” Programs and Policies on the Social Climate for Sexual-Minority Youth: A Review of the Literature , 2012 .

[32]  W. J. Meyer,et al.  Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 , 2012 .

[33]  E. Giltay,et al.  A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. , 2011, European journal of endocrinology.

[34]  R. Stotzer Violence against transgender people: A review of United States data , 2009 .

[35]  G. Currier,et al.  Behavioural Manifestations of Anabolic Steroid Use , 2005, CNS drugs.

[36]  J. Rosing,et al.  Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. , 2003, The Journal of clinical endocrinology and metabolism.

[37]  P. V. van Kesteren,et al.  Mortality and morbidity in transsexual subjects treated with cross‐sex hormones , 1997, Clinical endocrinology.

[38]  J. Prior,et al.  Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism , 1989, Archives of sexual behavior.